Demir, A. B. Et Al. 2023. Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.. Molecular biology reports , vol.50, no.10 , 8551-8563.

Demir, A. B., Baris, E., Kaner, U. B., Alotaibi, H., Atabey, N., & Koc, A., (2023). Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.. Molecular biology reports , vol.50, no.10, 8551-8563.

Demir, Ayse Et Al. "Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.," Molecular biology reports , vol.50, no.10, 8551-8563, 2023

Demir, Ayse B. Et Al. "Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.." Molecular biology reports , vol.50, no.10, pp.8551-8563, 2023

Demir, A. B. Et Al. (2023) . "Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.." Molecular biology reports , vol.50, no.10, pp.8551-8563.

@article{article, author={Ayse Banu Demir Et Al. }, title={Toll-interacting protein may affect doxorubicin resistance in hepatocellular carcinoma cell lines.}, journal={Molecular biology reports}, year=2023, pages={8551-8563} }